Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon.

Literature DB >> 23994440

Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon.

Phuong Vo¹, Elaine S Jaffe, Lisa Cook, Catalina Ramos, Richard Childs.

Abstract

Entities: Chemical Disease Gene Species

Keywords: Allogeneic hematopoietic stem cell transplantation; Bortezomib; Donor lymphocytes; Durable remission; Mantle cell lymphoma; PEG-interferon

Mesh：

Substances：

Year: 2013 PMID： 23994440 PMCID： PMC4146427 DOI： 10.1016/j.clml.2013.05.006

Source DB: PubMed Journal: Clin Lymphoma Myeloma Leuk ISSN： 2152-2669

× No keyword cloud information.

19 in total

Review 1. Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies.

Authors: David L Porter
Journal: Hematology Am Soc Hematol Educ Program Date: 2011

2. New strategies in the treatment of mantle cell lymphoma.

Authors: Changchun Deng; Sangmin Lee; Owen A O'Connor
Journal: Clin Cancer Res Date: 2012-06-14 Impact factor: 12.531

3. Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma.

Authors: Sascha Dietrich; Blanca Tielesch; Michael Rieger; Maike Nickelsen; Christiane Pott; Mathias Witzens-Harig; Michael Kneba; Norbert Schmitz; Antony D Ho; Peter Dreger
Journal: Cancer Date: 2010-11-29 Impact factor: 6.860

4. Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon.

Authors: Rolf E Brouwer; Pim van der Heiden; Geziena M T Schreuder; Arend Mulder; Gert Datema; Jacqy D H Anholts; Roel Willemze; Frans H J Claas; J H Frederik Falkenburg
Journal: Hum Immunol Date: 2002-03 Impact factor: 2.850

5. Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts.

Authors: Kozo Masuda; Akio Hiraki; Nobuharu Fujii; Toshiyuki Watanabe; Motoyuki Tanaka; Kosei Matsue; Yoichiro Ogama; Mamoru Ouchida; Kenji Shimizu; Kazuma Ikeda; Mitsune Tanimoto
Journal: Cancer Sci Date: 2007-01 Impact factor: 6.716

6. Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation.

Authors: Itzel Bustos Villalobos; Yoshiyuki Takahashi; Yoshiki Akatsuka; Hideki Muramatsu; Nobuhiro Nishio; Asahito Hama; Hiroshi Yagasaki; Hiroh Saji; Motohiro Kato; Seishi Ogawa; Seiji Kojima
Journal: Blood Date: 2010-02-01 Impact factor: 22.113

7. Loss of mismatched HLA in leukemia after stem-cell transplantation.

Authors: Luca Vago; Serena Kimi Perna; Monica Zanussi; Benedetta Mazzi; Cristina Barlassina; Maria Teresa Lupo Stanghellini; Nicola Flavio Perrelli; Cristian Cosentino; Federica Torri; Andrea Angius; Barbara Forno; Monica Casucci; Massimo Bernardi; Jacopo Peccatori; Consuelo Corti; Attilio Bondanza; Maurizio Ferrari; Silvano Rossini; Maria Grazia Roncarolo; Claudio Bordignon; Chiara Bonini; Fabio Ciceri; Katharina Fleischhauer
Journal: N Engl J Med Date: 2009-07-30 Impact factor: 91.245

Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon.

Review 1. Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies.

2. New strategies in the treatment of mantle cell lymphoma.

3. Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma.

4. Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon.

5. Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts.

6. Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation.

7. Loss of mismatched HLA in leukemia after stem-cell transplantation.

Review 8. The evolving contribution of hematopoietic progenitor cells to lymphomagenesis.

9. Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma.

Review 10. Pharmacology and therapeutic potential of interferons.

Review 1. Role of allogeneic stem cell transplantation in mantle cell lymphoma.